Citadel Advisors’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.18M Sell
999,400
-608,200
-38% -$3.81M ﹤0.01% 4281
2025
Q4
$11.8M Sell
1,607,600
-1,380,800
-46% -$13.4M ﹤0.01% 3051
2025
Q3
$29.8M Buy
2,988,400
+2,066,914
+224% +$22.9M ﹤0.01% 1882
2025
Q2
$8.34M Sell
921,486
-760,571
-45% -$4.96M ﹤0.01% 3294
2025
Q1
$10.8M Buy
1,682,057
+73,143
+5% +$651K ﹤0.01% 2750
2024
Q4
$15.3M Buy
1,608,914
+392,571
+32% +$3.45M ﹤0.01% 2462
2024
Q3
$9.94M Sell
1,216,343
-892,000
-42% -$9.26M ﹤0.01% 2902
2024
Q2
$28.5M Sell
2,108,343
-2,743
-0.1% -$22.9K 0.01% 1654
2024
Q1
$14.8M Buy
2,111,086
+1,189,829
+129% +$10.3M ﹤0.01% 2416
2023
Q4
$10.1M Sell
921,257
-281,143
-23% -$2.76M ﹤0.01% 2832
2023
Q3
$13.2M Sell
1,202,400
-412,229
-26% -$5.89M ﹤0.01% 2342
2023
Q2
$25.5M Buy
1,614,629
+865,943
+116% +$10.1M 0.01% 1641
2023
Q1
$9.77M Buy
748,686
+102,972
+16% +$846K ﹤0.01% 2848
2022
Q4
$7.03M Sell
645,714
-300,572
-32% -$3.7M ﹤0.01% 3324
2022
Q3
$15.2M Buy
946,286
+675,086
+249% +$9.97M ﹤0.01% 2200
2022
Q2
$2.11M Buy
271,200
+62,400
+30% +$587K ﹤0.01% 5433
2022
Q1
$2.61M Buy
208,800
+116,914
+127% +$1.64M ﹤0.01% 5493
2021
Q4
$2.19M Sell
91,886
-79,657
-46% -$1.93M ﹤0.01% 6022
2021
Q3
$2.83M Buy
171,543
+107,543
+168% +$1.62M ﹤0.01% 5502
2021
Q2
$1.29M Buy
+64,000
New +$868K ﹤0.01% 7691

Other funds holding ENVX

Citadel Advisors's ENVX Position: Q1 2026 in Review

Citadel Advisors increased its Enovix (ENVX) stake by 300% in Q1 2026, buying an estimated $3.69M and bringing the position to 785,329 shares worth $4.07M. The position accounts for ﹤0.01% of the portfolio, ranked #4683.

Citadel Advisors first reported a position in ENVX in Q3 2021 and has held it in 18 quarters since. The position peaked at $30.4M in Q2 2024. 306 funds tracked by Wall St. Rank hold ENVX as of Q1 2026.

  • Citadel Advisors held 785,329 shares of Enovix worth $4.07M as of Q1 2026.
  • Citadel Advisors bought 588,873 Enovix shares in Q1 2026, an estimated $3.69M.
  • Enovix made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4683 holding.
  • Citadel Advisors first reported a position in Enovix in Q3 2021 and has held it in 18 quarters since.
  • Citadel Advisors's Enovix position peaked at $30.4M in Q2 2024.
  • 306 funds tracked by Wall St. Rank held Enovix as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.